Resources

A library of articles, reports, podcasts and videos about open source drug discovery — the science, the policy and the movement behind affordable medicine for all.

Read

Articles / Blogs / Editorials28

Why open source pharma is the path to both new and cheaper medicines (opens in a new tab)
Matthew ToddThe GuardianArticle
What is Open Source Pharma (and Why Should You Care)? (opens in a new tab)
Andy UpdegroveSlashdotArticle
Message from Chief Mentor (opens in a new tab)
Samir BrahmachariOSDDArticlearchived copy
Prof Samir K. Brahmachari, Chief Mentor OSDD (opens in a new tab)
Open Source Drug DiscoveryArticlearchived copy
How open-source medicine could prepare us for the next pandemic (opens in a new tab)
Ruth ReaderFast CompanyArticle
If tuberculosis spreads… (opens in a new tab)
Polly J. PriceThe New York TimesArticle
Open Source Pharma and Prizes (opens in a new tab)
Matthew ToddIntermolecularArticle
Talking drug prices, Pt 6: Openness vs. secrecy in drug development (opens in a new tab)
Matthew ToddPLOSArticle
Four Reasons Drugs are Expensive, Of which Two are False (opens in a new tab)
Jack ScannellForbesArticle
Billion-dollar babies (opens in a new tab)
The EconomistArticle
A question of utility (opens in a new tab)
The EconomistArticle
Can Open Source Drug Development Deliver? (opens in a new tab)
Tatum AndersonThe LancetArticle
Can open science help patients and save pharma? (opens in a new tab)
Timothy KingArticle
International team of scientists open sources search for malaria cure (opens in a new tab)
Alice WilliamsonArticle
Making drug development less secretive could lead to quicker, cheaper therapies (opens in a new tab)
Matthew Todd & Alice WilliamsonArticle
Patents are eating the world and hurting innovation (opens in a new tab)
Walter FrickArticle
Rallying pharma's rebels (opens in a new tab)
Matthew HerperForbesArticle
Drugs for the poor, drugs for the rich (opens in a new tab)
Manica BalasegaramBMJArticle
A New Look At The Most Innovative Pharma Companies (And Whether They Are Sustainable) — Part I (opens in a new tab)
Bernard MunosForbesArticle
Beyond Heroism And Denial: How To Fortify Our Response To Ebola (opens in a new tab)
Bernard MunosForbesArticle
We the People vs. the Pharmaceutical Industry (opens in a new tab)
Bernard MunosForbesArticle
Pharmaceutical innovation gets a little help from new friends (opens in a new tab)
Bernard MunosArticle
Tata Trusts Support OSPF — the 'Linux for drugs' (opens in a new tab)
PT Jyothi DattaThe HinduArticle
"Linux for Drugs" (opens in a new tab)
BioSpectrum BureauArticle
The Collateral Benefits of India's Open Source Drug Discovery Programme (opens in a new tab)
Priyanka PullaForbes IndiaArticle
How Open Source Drug Discovery Is Helping India Develop New Drugs (opens in a new tab)
Seema SinghForbes IndiaArticle
The R-Factor: A Measure of Scientific Veracity (opens in a new tab)
Joshua Nicholson & Yuri LazebnikThe WinnowerArticle
System, crowd, and communal innovation: Can the monks solve the elephant? (opens in a new tab)
Shinya ItoArticle

Reports / Papers9

Adopting an Open-Source Approach to Pharmaceutical Research and Development (opens in a new tab)
Michael Stebbins, Miranda Bain, Rena Conti, Nicholaos Krenteras, Nicoleta Krenteras, Jaykumar Menon, Bernard MunosPaper
FDA clears IND for first clinical trial protocol developed using crowdsourcing (opens in a new tab)
Paper
Prizes, not patents (opens in a new tab)
Joseph E. StiglitzPaper
PUSH, PULL, POOL: Accelerating Innovation and Access to Medicines for Tuberculosis (opens in a new tab)
Médecins Sans FrontièresPaper
The Role of Patent Law in Regulating and Restricting Access to Medicines (opens in a new tab)
Luigi PalombiPaper
Prize-driven Innovation for Development (opens in a new tab)
IIT Delhi, Jaykumar Menon, Ambuj SagarPaper
Crowd computing: using competitive dynamics to develop and refine highly predictive models (opens in a new tab)
Joerg Bentzien, I. Muegge, B. Hamner, D.C. ThompsonPaper
Working towards sustainable software for science: Practice and experiences (opens in a new tab)
Curated by Matthew TurkPaper
Crowdsourcing clinical trial protocols (opens in a new tab)
Robert H. CarlsonPaper

Other3

Sage Bionetworks: Challenges (opens in a new tab)
Article
U.S. Medical Innovation Prize Fund Act (opens in a new tab)
Introduced by Senator Bernie SandersArticle
Incentives needed to further improve sharing of research data, says new report (opens in a new tab)
Wellcome TrustArticlearchived copy

Watch / Listen

Podcasts2

Entrepreneur joins group effort to cure millions (opens in a new tab)
Jaykumar MenonYour Mark on the WorldPodcastarchived copy
Innovating Vaccine Development (opens in a new tab)
Jaykumar MenonThe 2020 NetworkPodcast

Videos9

Balance Magazine interview with Samir Brahmachari (opens in a new tab)
Samir BrahmachariNRKVideo
Open Source Drug Discovery (OSDD) song — tuberculosis (opens in a new tab)
Video
Bitten by the Bug (opens in a new tab)
Melinda RichterTEDxAmericasFinestCityVideo
Kshaya Rog: Nayee Davayen, Nayee Chunatiyan Nayee Ashayen (opens in a new tab)
Dr. Jayanti DuttaVideo
5-minute short film by a child about TB
Video
Need of new drugs for TB: We need this (opens in a new tab)
Srigireesh RasiappanVideo
4-minute short film by students at PSG Institute of Medical Sciences and Research
Video
Beyond open access: Sharing research-derived knowledge with society (opens in a new tab)
Dr. John WillinskyVideo
OSDD videos (collection) (opens in a new tab)
Videoarchived copy

Join the Movement. Shape the Future of Open Science.

Help advance open science through AI, global collaboration, and accessible healthcare. Volunteer or donate to make a lasting impact.

Volunteer With Us Make a Donation